Latest Breaking News On - Resolution at regeneron pharmaceuticals - Page 1 : vimarsana.com

Explosive growth of antibody technology and therapeutics over the past three decades has driven development of antibody-centric patent case law across several fronts.

United statesJames evansEli lillyIdenix pharmsJohns hopkins universityPsys incJanssen biotech incImmunex corpUnited states district courtHybritech incPatent officeAriad pharm incWyeth cordis corpAbbvie deutschland gmbh coResolution at regeneron pharmaceuticalsJuno therapeutics inc